United States Supreme Court
Mutual Pharmaceutical Co., Inc. v. Bartlett, 12-142
State-law design-defect claims that turn on the adequacy of a drug's warnings are pre-empted by federal law under PLIVA. Inc. v. Mensing, which held that failure-to-warn claims against generic manufacturers are pre-empted by the Federal Food, Drug, and Cosmetic Act's prohibition on changes to generic drug labels.
Appellate Information
- Decided 06/24/2013
- Published 06/24/2013
Judges
- ALITO
Court
- United States Supreme Court